TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 31, 2024 Registration Statement No. 333-276505 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Evaxion Biotech A/S (Exact name of Registrant as specified in its charter) The Kingdom of Denmark (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Not appli ...